Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses
NCT ID: NCT01898260
Last Updated: 2015-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2013-08-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses (Study 2)
NCT01917162
Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses
NCT01707238
Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses
NCT02815735
A Clinical Comparison of Two Daily Disposable Soft Contact Lenses
NCT04005885
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT05483127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BYO Daily, then MyDay
Ultrafilcon B contact lenses, followed by stenfilcon A contact lenses. Each product worn bilaterally for 1 week in a daily wear, daily disposable modality.
Ultrafilcon B contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Stenfilcon A contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
MyDay, then BYO Daily
Stenfilcon A contact lenses, followed by ultrafilcon B contact lenses. Each product worn bilaterally for 1 week in a daily wear, daily disposable modality.
Ultrafilcon B contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Stenfilcon A contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrafilcon B contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Stenfilcon A contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spherical distance contact lens prescription between -1.00 and -6.00 diopter (inclusive);
* Spectacle cylinder ≤0.75 diopter in the least astigmatic eye, ≤1.00 diopter in the other;
* Correctable to 6/9 (20/30) in both eyes;
* Read, understood and signed the informed consent;
* Willing to comply with the wear schedule;
* Willing to comply with the study visit schedule;
Exclusion Criteria
* Systemic or ocular allergies which might interfere with contact lens wear;
* Systemic or ocular disease which might interfere with contact lens wear;
* Strabismus or amblyopia;
* Corneal refractive surgery and any anterior segment surgery;
* Use of systemic/topical medication contraindicating contact lens wear;
* Use of gas permeable contact lenses within 1 month preceding the study;
* Participation in any concurrent clinical trial or in the last 30 days;
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joachim Nick, Dipl. Ing.
Role: STUDY_DIRECTOR
Alcon Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Surrey, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-13-032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.